A new vaccine technique can fight a certain type of breast cancer in mice. So-called HER2-positive breast cancer accounts for between 20 and 30 percent of all cases of breast cancer in humans.

Understanding how the human immune system fights Plasmodium vivax paves the way for the first effective vaccine against it.

Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

Receiving two doses of inactivated influenza vaccine (IIV) in the first year of influenza vaccination is associated with improved protection for children younger than 3 years versus one dose, ...

Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

Researchers have invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens – the closest yet to a universal vaccine. In the realm of medical advancements, a universal ...